Evidence map›Paper›PMID 31689907›Full record

ArticleMetabolites2019

Exposure of HepaRG Cells to Sodium Saccharin Underpins the Importance of Including Non-Hepatotoxic Compounds When Investigating Toxicological Modes of Action Using Metabolomics.

Matthias Cuykx, Charlie Beirnaert, Robim Marcelino Rodrigues, Kris Laukens, Tamara Vanhaecke, Adrian Covaci

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthias CuykxToxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. matthiascuykx@gmail.com.
Charlie BeirnaertDepartment of Mathematics & Computer Science, University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium. Charlie.beirnaert@uza.be.
Robim Marcelino RodriguesResearch Group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium. Robim.marcelino.rodrigues@vub.be.
Kris LaukensDepartment of Mathematics & Computer Science, University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium. Kris.laukens@uantwerpen.be.ORCID 0000-0002-8217-2564
Tamara VanhaeckeResearch Group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium. Tamara.vanhaecke@vub.be.
Adrian CovaciToxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Adrian.Covaci@uantwerpen.be.ORCID 0000-0003-0527-1136
University of Antwerp · BEVrije Universiteit Brussel · BE

Funding

Fonds voor wetenschappelijk onderzoek (FWO) Belgium 12H2216N and 11Z3318N
6 · The paper itself

Abstract

Metabolites represent the most downstream information of the cellular organisation. Hence, metabolomics experiments are extremely valuable to unravel the endogenous pathways involved in a toxicological mode of action. However, every external stimulus can introduce alterations in the cell homeostasis, thereby obscuring the involved endogenous pathways, biasing the interpretation of the results. Here we report on sodium saccharin, which is considered to be not hepatotoxic and therefore can serve as a reference compound to detect metabolic alterations that are not related to liver toxicity. Exposure of HepaRG cells to high levels of sodium saccharin (>10 mM) induced cell death, probably due to an increase in the osmotic pressure. Yet, a low number (

Indexed as

HepaRGin vitroreference toxicantssodium saccharin

Identifiers

PMID31689907
PMCPMC6918164
OpenAlexW2985015104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.